Design of Pistacia lentiscus (mastic gum) controlled release spheroids and investigating the influence of roll compaction

Industrial Crops and Products

Volumn 44, Issue , 2013, Pages 603-610

  Deshpande, Rohan D ^a   Gowda, D V ^a   Mahammed, Nawaz ^a  

^a JSS COLLEGE OF PHARMACY   (India)

Author keywords

Diclofenac sodium; Extrusion spheronization; Mastic gum; Roll compacted tablets

Indexed keywords

AVERAGE SIZE; BULK DENSITY; COMPRESSION FORCE; CONTROLLED RELEASE; DICLOFENAC SODIUM; DRUG CONTENT; DRUG RELEASE; EXTRUSION-SPHERONIZATION; FLOW PROPERTIES; GUM CONCENTRATION; IN-VITRO; MASTIC GUM; MICROCRYSTALLINE CELLULOSE; PISTACIA LENTISCUS; ROLL COMPACTED TABLETS; ROLL COMPACTION; SUSTAINED RELEASE; TABLETING;

DRUG PRODUCTS; SODIUM;

COMPACTION;

BULK DENSITY; COMPACTION; CONCENTRATION (COMPOSITION); DRUG; MORPHOLOGY; RELATIVE HUMIDITY; SHRUB; SODIUM; SURFACE;

PISTACIA; PISTACIA LENTISCUS;

EID: 84872497781     PISSN: 09266690     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.indcrop.2012.09.014     Document Type: Article

References (39)

1. Al-Habbal M.J., Al-Habbal Z., Huwez F.U. A double-blind controlled clinical trial of mastic and placebo in the treatment of duodenal ulcer. Clin. Exp. Pharmacol. Physiol. 1984, 5:541-544.
2. Al-said M.S., Ageel A.M., Parmar N.S., Tariq M. Evaluation of mastic, a crude drug obtained from Pistacia lentiscus for gastric and duodenal anti-ulcer activity. J. Ethnopharmacol. 1986, 15:271-278.
3. Azeez O.S. Production of gum from cashew tree latex. Leonardo Electron. J. Pract. Technol. 2005, 7:17-22.
4. Balan K.V., Prince J., Han Z., Dimas K., Cladaras M., Wyche J.H., Sitaras N.M., Pantazis P. Antiproliferative activity and induction of apoptosis in human colon cancer cells treated in vitro with constituents of a product derived from Pistacia lentiscus L. Var. Chia. Phytomedicine 2007, 14(4):263-272.
5. Baveja S.K., Rangarao K.V., Arora J. Examination of natural gums and mucilages as sustaining materials in tablet dosage forms. Indian J. Pharm. Sci. 1988, 50:89-92.
6. Chatlapalli R., Rohera B.D. Physical characterization of HPMC and HEC and investigation of their use as pelletization aids. Int. J. Pharm. 1998, 161:179-193.
7. Chatlapalli R., Rohera B.D. Rheological characterization of diltiazem HCl:cellulose wet masses using a mixer torque rheometer. Int. J. Pharm. 1998, 175:47-59.
8. Chaudhari M.P., Chaudhari D.P. Formulation and evaluation of multiparticulate system for chronotherapeutic delivery of salbutamol sulphate. J. Pharm. Bioallied Sci. 2012, 4:S71-S73.
9. Cosijins A., Nizet D., Nikolokakis I. Porous pellets as drug delivery system. Drug Dev. Ind. Pharm. 2009, 35(6):655-662.
10. Cox P.H., Spanjers F. The preparation of sterile implants by compression. Pharm. Weekblad 1970, 105:681-684.
11. Davies S.S., Wilson C.G., Washington N. Gastrointestinal transit of a controlled-release pellet formulation of tiaprofenic acid and the effect of food. Int. J. Pharm. 1987, 35:253-258.
12. Deshpande R.D., Gowda D.V., Vasanti S., Mahammed N. Design of polypill for treatment of type-II diabetes mellitus associated with dyslipidemia. J. Sci. Ind. Res. 2012, 71:556-561.
13. Dimas K., Hatziantonio S., Wyche J.H., Pantazis P. A mastic gum extract induces suppression of growth of human colorectal tumor xenografts in immunodeficient mice. In Vivo 2009, 23(1):63-68.
14. Du Pasquier A., Disma F., Bowmer T., Gozdz A.S., Amatucci G., Tarascon J.M. Differential scanning calorimetry studies of lithium ion and the reactivity of carbon anodes in plastic lithium ion batteries. J. Electrochem. Soc. 1998, 145(2):472-477.
15. Erkoboni K.A. Extrusion/spheronization. Pharmaceutical Extrusion Technology 2003, 277-322. Marcel Dekker Inc., New York/Basel. I. Ghebre-Sellassie, C. Martin (Eds.).
16. Feely L.C., Khosla R., Davis S.S. Investigating the gastric emptying of different sizes of non-disintegrating tablets in humans using gamma scintigraphy. J. Pharm. Pharmacol. 1987, 39:31.
17. Gajdos B. Rotary granulators-evaluation of process technology for pellet production using factorial design. Drugs Made Ger. 1984, 27:30-36.
18. Ghali E.S., Contractor A.M., Mankad A.D., O'Connor R.E., Schwartz A high-speed mixer for continuous wet granulation. Pharm. Technol. 1990, (April):60-66.
19. Ghebre-Sellassie I. Pharmaceutical Pelletization Technology 1989, Marcel Dekker, New York, (Chapter 1).
20. Hicks D.S., Freese H.L. Extrusion and spheronizing equipment. Pharmaceutical Pelletisation Technology 1989, Marcel Dekker Inc., New York/Basel, pp. 71-100.
21. Huwez F.U., Al-Habbal M.J. Mastic in treatment of benign gastric ulcers. J. Gastroenterol. 1986, 3:273-274.
22. Iosio T., Voinovich D., Grassi M., Pinto J.F., Perissutti B., Zacchigna M., Quintavalle U., Serdoz F. Bi-layered self-emulsifying pellets prepared by co-extrusion and spheronization: influence of formulation variables and preliminary study on the in vivo absorption. Eur. J. Pharm. Biopharm. 2008, 69:686-697.
23. Kiortsis s., Kachrimanis K., Broussali T., Malamataris S. Drug release from tableted wet granulations comprising cellulosic (HPMC or HPC) and hydrophobic component. Eur. J. Pharm. Biopharm. 2005, 59:73-83.
24. Kristensen H.G., Schaefer T. Granulation. A review of pharmaceutical wet granulation. Drug Dev. Ind. Pharm. 1987, 13:803-872.
25. Kulkarni G.T., Gowthamarajan K., Brahmajirao G., Suresh B. Evaluation of binding properties of selected natural mucilages. J. Sci. Ind. Res. 2002, 61:529-532.
26. Liu J. Oleanolic acid and ursolic acid: research perspectives. J. Ethnopharmacol. 2005, 100:92-94.
27. Mallipeddi R., Saripella K.K., Neau S.H. Use of coarse ethylcellulose and PEO in beads produced by extrusion-spheronization. Int. J. Pharm. 2010, 385:53-65.
28. Niskanen, M., 1992. Powder layering and coating in a centrifugal granulator: effect of binder-solution concentration, powder particle size and coating amount on pellets properties. Ph.D. Thesis, University of Helsinki.
29. Preparing Modified Release Multiparticulate Dosage Forms With Eudragit Polymers, 2002. Pharma Polym. News, 9, 2-3.
30. Rowe R.C. Spheronization: a novel pill-making process. Pharm. Int. 1985, 6:119-123.
31. Reynolds A.D. A new technique for the production of spherical particles. Manuf. Chem. Aerosol News 1970, (June):39-43.
32. Umprayn K., Chitropas P., Amarekajorn S. Influence of process variables on physical properties of the pellets using extruder and spheronizer. Drug Dev. Ind. Pharm. 1999, 21(1):45-61.
33. US Pharmacopeia US Pharmacopeia-XXIV, NF-XXIX 2000, US Pharmacopoeial Convention, Rockville, MD.
34. Vertommen J., Rombaut P., Kinget R. Shape and surface smoothness of pellets made in a rotary processor. Int. J. Pharm. 1997, 146:21-29.
35. Vervaet C., Baert L., Remon J.P. Extrusion-spheronisation - a literature-review. Int. J. Pharm. 1995, 116:131-146.
36. Wan L.S.C., Lai W.F. Factors affecting drug release from drug-coated granules prepared by fluidized-bed coating. Int. J. Pharm. 1991, 72:163-174.
37. Wlosnewskia J.C., Kumpugdee-Vollrathc M., Sriamornsaka P. Effect of drying technique and disintegrant on physical properties and drug release behaviour of microcrystalline cellulose-based pellets prepared by extrusion/spheronization. Chem. Eng. Res. Des. 2010, 88:100-108.
38. Wong T.W., Chan L.W., Lee H.Y., Heng P.W. Release characteristics of pectin microspheres prepared by an emulsification technique. J. Microencapsulation 2002, 19(4):511-522.
39. Zheng W., Sauer D., McGinity J.W. Influence of hydroxyethylcellulose on the drug release properties of theophylline pellets coated with Eudragit RS 30 D. Eur. J. Pharm. Biopharm. 2005, 59(1):147-154.